Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 3
Submit an article Journal homepage
723
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma

M. ArenbergerovaDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicCorrespondence[email protected]
View further author information
,
S. GkalpakiotisDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicORCID Iconhttps://orcid.org/0000-0002-6956-5961View further author information
ORCID Icon,
P. ArenbergerDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicView further author information
,
A. FialovaDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicView further author information
&
M. PasekDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicView further author information
Pages 1782-1783 | Received 13 Jun 2020, Accepted 28 Jun 2020, Published online: 22 Oct 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma." Journal of Dermatological Treatment, 33(3), pp. 1782–1783

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The work was supported by the PROGRES Q28 (oncology) research program awarded by the Charles University, Prague.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.